Salix Pharmaceuticals received an FDA approval for Metozolv (metoclopramide), a treatment for diabetic gastroparesis and gastroesophageal reflux disease (GERD). The drug was approved for short-term use, from four to 12 weeks.
Sun Pharma's branded prostate cancer treatment Yonsa just received FDA approval.
Amgen and Novartis enlisted Arnold Worldwide, Wavemaker, and Starcom Media Group for its Speak Your Migraine campaign.
Novocure and Glue Advertising put on a Facebook Live event promoting the cancer treatment Optune in March.